News

A new RAND study uncovers significant differences between healthcare costs paid by privately insured patients and those paid out by Medicare.

Offering multiple, segmented approaches to health can confuse consumers-and reduce engagement. Instead, focus efforts on comprehensive solutions.

Healthcare treatment compliance can be difficult for patients facing other issues like unaddressed SDOH problems or mental health diseases. Here are four ways to engage those members.

As pharmacies get deeper into chronic care treatment, what will it mean for both pharmacy and the world of managed care?

As the shift to value-based payment accelerates, successful health organizations can take steps to build an effective quality management program that will improve HEDIS scores and deliver care quality and cost savings.

A proposed policy calling for hospitals to publicly disclose negotiated prices charged for services is drawing ire from some hospitals and insurance companies.

From disruptive technology to regulatory ‘known-unknowns’ to the plight of today’s healthcare consumer, 2019 is shaping up to be a year of extraordinary transformation.

Generic drug makers are defending their practices after 44 US states accused Teva Pharmaceuticals and other pharma makers of conspiring to inflate their prices in a lawsuit.

A new government rule requiring pharma makers to disclose drug prices in television ads will likely create more confusion for consumers, analysts and organizations said.

The United States pays much higher drug prices than other countries. Could reference pricing be the fix?

A new report assesses the viability of new healthcare expansion options with Medicaid insurers.

Managed Healthcare Executive has identified 10 emerging industry leaders, working in the areas of pharmacy, health plans, health systems, and technology.

Drug costs are a hot political topic, but just how much do they disrupt healthcare?

Asembia offers broad coverage across specialty pharmacy.

Stronger warnings on popular insomnia medications could have an impact on prescribing, some experts say.

While FDA approved the second biosimilar drug to Enbrel, the success of the medication hinges on a pending lawsuit. 

How to make your LinkedIn profile stand out and work for you.

Key ways healthcare executives can improve therapy compliance.

Pharmacists are in a unique position to improve orphan drug and precision medicine channels.

Experts offer their thoughts on what the specialty pharmacy industry will look like over the next year.

As the healthcare landscape continues to change at a rapid pace, drug manufacturers need to take a long, hard look at their marketing and commercialization options.

From tips for new healthcare leaders to growing initiatives, Andrea Walsh shows why people are the most important part of every part of healthcare.

At the 2019 Asembia Specialty Pharmacy Summit, Cardinal Health’s Bruce Feinberg articulates the pros and cons of copay accumulator programs.

The present and bright future of cholesterol treatments.

OptumRx will expand its drug discounts to employer-sponsored health plans starting next year. Here’s what the move means for healthcare.

CDC commentary claims patients taken off opiods too soon.

A new report determines the trends fueling drug research and development over the past 10 years-and into the future.

As a healthcare executive, it’s your job to excite and inspire your leadership team to bring their A-game. Here are six powerful ways.

Patients taking heart medications are most at risk when a pharmacy shuts its doors.

The first step to tackling one of healthcare’s biggest problems is to gain more complete access to patient data.